These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14980547)

  • 1. Universal red blood cells--enzymatic conversion of blood group A and B antigens.
    Olsson ML; Hill CA; de la Vega H; Liu QP; Stroud MR; Valdinocci J; Moon S; Clausen H; Kruskall MS
    Transfus Clin Biol; 2004 Feb; 11(1):33-9. PubMed ID: 14980547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying the red cell surface: towards an ABO-universal blood supply.
    Olsson ML; Clausen H
    Br J Haematol; 2008 Jan; 140(1):3-12. PubMed ID: 17970801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of group O cells.
    Lenny LL; Goldstein J
    Biotechnology; 1991; 19():75-100. PubMed ID: 1664756
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs.
    Garratty G
    Transfus Med Rev; 2004 Oct; 18(4):245-56. PubMed ID: 15497125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation of transfusable human universal red blood cell with recombinant alpha-galactosidase].
    Gong F; Lü QS; You Y; Gao HW; Bao GQ; Gao X; Li SB; Li LL; Wang YL; Tian SG; Zhang ZX; Zhang P; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):313-6. PubMed ID: 15854299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O.
    Kruskall MS; AuBuchon JP; Anthony KY; Herschel L; Pickard C; Biehl R; Horowitz M; Brambilla DJ; Popovsky MA
    Transfusion; 2000 Nov; 40(11):1290-8. PubMed ID: 11099655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial glycosidases for the production of universal red blood cells.
    Liu QP; Sulzenbacher G; Yuan H; Bennett EP; Pietz G; Saunders K; Spence J; Nudelman E; Levery SB; White T; Neveu JM; Lane WS; Bourne Y; Olsson ML; Henrissat B; Clausen H
    Nat Biotechnol; 2007 Apr; 25(4):454-64. PubMed ID: 17401360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.
    Lenny LL; Hurst R; Goldstein J; Galbraith RA
    Transfusion; 1994 Mar; 34(3):209-14. PubMed ID: 8146892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward universal donor blood: Enzymatic conversion of A and B to O type.
    Rahfeld P; Withers SG
    J Biol Chem; 2020 Jan; 295(2):325-334. PubMed ID: 31792054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards universally acceptable blood.
    Clausen H; Olsson ML
    Nat Microbiol; 2019 Sep; 4(9):1426-1427. PubMed ID: 31439931
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research advance on universal red blood cell engineering].
    Tan YX; Ji SP; Gong F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):814-9. PubMed ID: 21729578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proof of homologous blood transfusion through quantification of blood group antigens.
    Nelson M; Popp H; Sharpe K; Ashenden M
    Haematologica; 2003 Nov; 88(11):1284-95. PubMed ID: 14607758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel GH109 enzymes for bioconversion of group A red blood cells to the universal donor group O.
    Curci N; Iacono R; Segura DR; Cillo M; Cobucci-Ponzano B; Strazzulli A; Leonardi A; Giger L; Moracci M
    N Biotechnol; 2023 Nov; 77():130-138. PubMed ID: 37643666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials.
    Lenny LL; Hurst R; Zhu A; Goldstein J; Galbraith RA
    Transfusion; 1995; 35(11):899-902. PubMed ID: 8604485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of group A1B erythrocytes converted to type as group O: studies of markers of function and compatibility.
    Gao HW; Zhuo HL; Zhang X; Ji SP; Tan YX; Li SB; Jia YJ; Xu H; Wu QF; Yun ZM; Luo Q; Gong F
    Blood Transfus; 2016 Mar; 14(2):168-74. PubMed ID: 26509826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case for stocking O D+ red blood cells in emergency room trauma bays.
    Meyer E; Uhl L
    Transfusion; 2015 Apr; 55(4):791-5. PubMed ID: 25444310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Naja naja atra cardiotoxin 3 with H-trisaccharide modulates its hemolytic activity and membrane-damaging activity.
    Kao PH; Lin SR; Chang LS
    Toxicon; 2010 Jun; 55(7):1387-95. PubMed ID: 20193704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood.
    Jensen M; Stenfelt L; Ricci Hagman J; Pichler MJ; Weikum J; Nielsen TS; Hult A; Morth JP; Olsson ML; Abou Hachem M
    Nat Microbiol; 2024 May; 9(5):1176-1188. PubMed ID: 38684911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell antigens as functional molecules and obstacles to transfusion.
    Garratty G; Telen MJ; Petz LD
    Hematology Am Soc Hematol Educ Program; 2002; ():445-62. PubMed ID: 12446436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.